| Disrupted endothelial cell heterogeneity and network organization impair vascular function in prediabetic obesity C Wilson, X Zhang, MD Lee, M MacDonald, HR Heathcote, NMN Alorfi, ... Metabolism 111, 154340, 2020 | 31 | 2020 |
| Pharmacological methods of pain management: Narrative review of medication used NM Alorfi International Journal of General Medicine, 3247-3256, 2023 | 13 | 2023 |
| Clinical impact of semaglutide, a glucagon-like peptide-1 receptor agonist, on obesity management: a review NM Alorfi, AS Algarni Clinical pharmacology: advances and applications, 61-67, 2022 | 13 | 2022 |
| Pharmacological treatments of fibromyalgia in adults; overview of phase IV clinical trials NM Alorfi Frontiers in Pharmacology 13, 1017129, 2022 | 12 | 2022 |
| Usage of glucagon-like peptide-1 for obesity in children; updated review of Clinicaltrials. gov NM Alorfi, FS Alshehri Journal of Multidisciplinary Healthcare, 2179-2187, 2023 | 8 | 2023 |
| Linagliptin and empagliflozin inhibit microtubule affinity regulatory kinase 4: Repurposing anti-diabetic drugs in neurodegenerative disorders using in silico and in vitro … A Atiya, D Das Gupta, A Alsayari, M Alrouji, A Alotaibi, SE Sharaf, ... ACS omega 8 (7), 6423-6430, 2023 | 7 | 2023 |
| Public awareness of Alzheimer’s disease: a cross-sectional study from Saudi Arabia NM Alorfi International Journal of General Medicine 15, 7535, 2022 | 6 | 2022 |
| Exploring the knowledge, attitude and practice towards disaster medicine preparedness and readiness: A prescriptive insight by the community pharmacists in the United Arab Emirates AA Jairoun, SS Al-Hemyari, M Shahwan, NM Alorfi, F El-Dahiyat, ... Plos one 17 (8), e0273209, 2022 | 5 | 2022 |
| Assessment of the community pharmacists’ knowledge and attitudes toward pain and pain management in Saudi Arabia NM Alorfi, AM Ashour, AS Algarni, FA Alsolami, AM Alansari, M Tobaiqy International Journal of General Medicine 15, 8527, 2022 | 5 | 2022 |
| NAFLD and nutraceuticals: A review of completed phase III and IV clinical trials OE Hegazi, SO Alalalmeh, GRH Alnuaimi, M Shahwan, AA Jairoun, ... Frontiers in Medicine 10, 1227046, 2023 | 4 | 2023 |
| Assessment of community pharmacists' knowledge about drug-drug interactions in Jeddah, Saudi Arabia NM Alorfi, RS Alqurashi, AS Algarni Frontiers in Pharmacology 14, 1516, 2023 | 4 | 2023 |
| A Study to Assess Prescription Transfer and Medicines Collection Through a New Electronic Prescription Service: A Cross-Sectional Survey M Tobaiqy, BE Ainousah, NM Alorfi, A Alghamdi, ST Alqutub International Journal of General Medicine, 3689-3699, 2023 | 3 | 2023 |
| Desmodin and isopongachromene as potential inhibitors of cyclin-dependent kinase 5: phytoconstituents targeting anticancer and neurological therapy A Atiya, S Batra, T Mohammad, NM Alorfi, WA Abdulmonem, ... Journal of Biomolecular Structure and Dynamics 41 (16), 8042-8052, 2023 | 3 | 2023 |
| The Impact of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease in Older Adults: A Review of Clinicaltrials. gov Registry NM Alorfi, AM Ashour Diabetes, Metabolic Syndrome and Obesity, 3115-3121, 2023 | 3 | 2023 |
| Biologic therapy for refractory immune checkpoint inhibitor colitis NM Alorfi, MM Alourfi Biologics: Targets and Therapy, 119-127, 2022 | 3 | 2022 |
| Role of lisinopril in the therapeutic management of cardiovascular disease by targeting microtubule affinity regulating kinase 4: molecular docking and molecular dynamics … A Atiya, A Alsayari, A Bin Muhsinah, D Almaghaslah, AL Bilgrami, ... Journal of Biomolecular Structure and Dynamics 41 (18), 8824-8830, 2023 | 2 | 2023 |
| Characterization of interventional clinical trials for monkeypox; Systematic review of ClinicalTrials. gov database N Alorfi, FS Alshehri, A Haseeb Frontiers in Public Health 11, 826, 2023 | 2 | 2023 |
| Community Pharmacists' Perspectives on Cardiovascular Disease Pharmaceutical Care in the United Arab Emirates: A Questionnaire Survey-Based Analysis AA Jairoun, SS Sabaa, M Shahwan, FS Alshehri, NM Alorfi, M Al Ani, ... Frontiers in Pharmacology 14, 1237717, 2023 | 2 | 2023 |
| Protective role of resveratrol against VCM-induced hepatotoxicity in male Wistar rats FS Alshehri, NM Alorfi Frontiers in Pharmacology 14, 260, 2023 | 2 | 2023 |
| Exploring Promising Therapies for Non-Alcoholic Fatty Liver Disease: A ClinicalTrials. gov Analysis OE Hegazi, SO Alalalmeh, M Shahwan, AA Jairoun, MM Alourfi, ... Diabetes, Metabolic Syndrome and Obesity, 545-561, 2024 | 1 | 2024 |
Fahad S AlshehriAssociate Professor, Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University在 uqu.edu.sa 的电子邮件经过验证
